Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Perry A. Karsen currently holds 164,034 shares of OncoMed Pharmaceuticals Inc (OMED), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Perry A. Karsen has been a net seller of OMED stock. They have purchased $34.6K and sold $39.1M worth of shares.
Perry A. Karsen's most recent insider trade was on May 3, 2023, when they sold 5,000 shares at $0.00 per share.
Perry A. Karsen serves as Executive at OncoMed Pharmaceuticals Inc (OMED). They have executed 58 insider transactions totaling $39.2M over their tenure at the company.
Perry A. Karsen holds the position of Executive at OncoMed Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Perry A. Karsen has shown a selling trading pattern, with $34.6K in total purchases and $39.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Perry A. Karsen was on Nov 12, 2014, when they sold $4.2M worth of CELG shares. This transaction involved 39,420 shares at $107.23 per share.
Perry A. Karsen currently owns 164,034 shares of OncoMed Pharmaceuticals Inc (OMED), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Perry A. Karsen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Perry A. Karsen has 58 Form 4 filings on record as an insider at OncoMed Pharmaceuticals Inc.
Set alerts for Perry A. Karsen and 40,000+ other insiders.